Abstract: An imaging member including: a pressing member that presses a breast of a subject; and an ultrasonography member that has a first surface on which an acoustic matching member having fluidity is provided, and is provided such that a second surface on a side opposite to the first surface is provided on a surface of the pressing member, which is on a side opposite to a surface that comes into contact with the breast, via a coupling material having lower fluidity than the acoustic matching member.

Abstract: A substance that can be a substitute for amylospheroids (ASPD) and a method for analyzing ASPD are provided. Viewed from one aspect, the present disclosure relates to a substance in which amyloid-? protein (A?) is cross-linked with a cross-linking agent that has a spacer arm length of between 4 ? and 50 ? inclusive or a cross-linking agent that has, as a spacer arm, not less than 1 and not more than 13 groups that are an oxyethylene group(s) (—CH2CH2O—) and/or an oxypropylene group(s) (—CH2CH2CH3O—). Viewed from another aspect, the present disclosure relates to a method for analyzing ASPD using the substance as a reference material.

Abstract: Provided are a cell secreted-type amylospheroids-like structure, a drug and vaccine using the same, as well as a method of producing the same. In one aspect, the present disclosure relates to a production method including a step of culturing, in a culture medium, cells that express an amyloid precursor protein (APP) or a part thereof containing an amyloid beta-protein (Aß) sequence to obtain a cell secreted-type amylospheroids (ASPD)-like structure in said culture medium.

Abstract: The present invention provides a compound of Formula I for use in the treatment, amelioration and/or prevention of diseases and conditions associated with CETP activity, such as atherosclerosis and dyslipidemia, in a subject with high triglyceride level; wherein R1, X1, R7, R5, C, L and p are defined herein. The present invention further provides a combination of pharmacologically active agents for use in the treatment, amelioration and/or prevention of diseases and conditions associated with CETP activity, such as atherosclerosis and dyslipidemia, in a subject with high triglyceride levels.

Abstract: The present invention provides a compound of Formula I: for use in the treatment, amelioration and/or prevention of diseases and conditions associated with CETP activity, such as atherosclerosis and dyslipidemia, in a subject with high triglyceride level; wherein R1, X1, R7, R5, C, L and p are defined herein. The present invention further provides a combination of pharmacologically active agents for use in the treatment, amelioration and/or prevention of diseases and conditions associated with CETP activity, such as atherosclerosis and dyslipidemia, in a subject with high triglyceride levels.

Abstract: The present invention provides a compound of Formula I: for use in the treatment, amelioration and/or prevention of diseases and conditions associated with CETP activity, such as atherosclerosis and dyslipidemia, in a subject with high triglyceride level; wherein R1, X1, R7, R5, C, L and p are defined herein. The present invention further provides a combination of pharmacologically active agents for use in the treatment, amelioration and/or prevention of diseases and conditions associated with CETP activity, such as atherosclerosis and dyslipidemia, in a subject with high triglyceride levels.

Abstract: The printing ink of the present invention is characterized by containing a photo-curable high polymer precursor, and a photopolymerization initiator, and containing 3 to 8 parts by weight of inorganic fine particles having a mean particle size of 0.1 ?m or less to 100 parts by weight of the high polymer precursor. Moreover, the printing ink of the present invention is characterized by having a viscosity at a shear rate of 5 (l/s) of 8 to 75 (Pa·s), a viscosity at a shear rate of 20 (l/s) of 3 to 25 (Pa·s), and a thixotropic index value of 1.5 to 3.5. As a result of using this printing ink, letters, figures, symbols, graphics, etc., having a thickness of 0.2 mm or more can be printed rapidly without affecting the printed base material.